Necrosis, cysts, hemorrhage, and calcification represent common findings in renal cell carcinoma. Different lesions, including arteriosclerosis or fibromuscular dysplasia, or both, may involve the main renal artery. This study analyzed the relationship between the presence and extent of necrosis in renal cell carcinoma with renal artery changes in a consecutive series of 112 patients (71 men, 41 women) with mean renal cell carcinoma of 7.7 cm (range, 2 to 20 cm). Necrosis was seen macroscopically and confirmed microscopically in 88 cases (78.6%), with 64 tumors having less than 50% and 24 more than 50% necrosis. Fibromuscular dysplasia was found in 41 patients (36.6%; 17 men, 24 women) and atherosclerotic changes in 21 patients (18.8%; 18 men, 3 women). The results suggest that necrosis of renal cell carcinoma was significantly more common in women with associated fibromuscular dysplasia (especially type I) and men with atherosclerotic changes of renal artery.
Eble JN, Sauter G, Epstein JI, Sesterhenn IA (eds). Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs (World Health Organization classification of tumours). Lyon, France: International Agency for Research on Cancer Press; 2004.
2.
Rosai J (ed). Rosai and Ackerman’s Surgical Pathology. St Louis, MO: Mosby; 2004.
3.
Frank I, Blute ML, Cheville JC, Lohse CM, Weaver AL, Zincke H.An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy used on tumor stage, size, grade and necrosis: the SSIGN score. J Urol.2002;168: 2395-2395:2400-2400.
4.
Hemmerlein B, Kugler A, Olisik R, Ringert RH, Radzun HJ, Thelen P.Vascular endothelial growth factor expression, angiogenesis, and necrosis in renal cell carcinomas. Virchows Arch. 2001;439: 645-652.
5.
Sengupta S, Lohse CM, Leibovitz BC, et al.Histologic coagulative tumor necrosis as a prognostic indicator of renal cell carcinoma aggressiveness. Cancer.2005;104: 511-520.
Heffelinger MJ, Holley KE, Harrison EG JR, Hunt JC.Arterial fibromuscular dysplasia studied at autopsy. Am J Clin Pathol. 1970;54: 274-274.
9.
Fenves AZ, Ram VS.Fibromuscular dysplasia of the renal arteries. Curr Hypertens Rep. 1999;1: 544-549.
10.
Nickeleit V, Moll S, Cynke E, Brunner FP, Michatsch M.A young woman with high blood pressure on haemodialysis: it is never too late to evaluate hypertension. Nephrol Dial Transplant. 1999;14: 2734-2737.
11.
Stanley JC, Gewertz BL, Bove EL, Sottiurai V, Fry WJ.Arterial fibrodysplasia. Histopathologic character and current etiologic concepts. Arch Surg. 1975;110: 561-566.
12.
Youngberg SP, Sheps SG, Strong CG.Fibromuscular disease of the renal arteries. Med Clin North Am. 1977; 61: 623-641.
13.
Fuhrman SA, Lasky LC, Limas C.Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982;6: 655-663.
14.
Thoenes W, Storkel S, Rumpelt HJ.Histopathology and classification of renal cell tumors (adenomas, oncocytomas and carcinomas). The basic cytological and histopathological elements and their use for diagnosis. Pathol Res Pract. 1986;181: 125-143.
15.
Costa J, Wesley RA, Glatstein E, Rosenberg SA.The grading of soft tissue sarcomas. Results of a clinicohistopathologic correlation in a series of 163 cases. Cancer. 1984; 53: 530-541.
16.
Trojani M, Contesso G, Coindre JM, et al.Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer. 1984; 33: 37-42.
17.
Tomić K, Tomas D, Tomašković I, Kos M, Belicza M, Krušlin B.Renal artery changes in patients with primary renal cell carcinoma. Virchows Arch.2006;448: 24-28.
18.
Onishi Y, Goto H, Yanada S, Abe K.Histological features of hypovascular or avascular renal cell carcinoma: the experience at four university hospitals. Int J Clin Oncol.2002;7: 159-164.
19.
Stoeckle E, Coindre JM, Bonvalot S, et al; French Federation of Cancer Centers Sarcoma Group. Prognostic factors in retroperitoneal sarcoma. A multivariate analysis of a series of 165 patients of the French Cancer Federation Sarcoma Group. Cancer. 2001; 92: 359-368.
20.
Coindre JM, Trojani M, Contesso G, et al.Reproducibility of a histopathologic grading system for adult soft tissue sarcoma. Cancer. 1986; 58: 306-309.
21.
Linehan WM, Vasselli J, Srinivasan R, et al.Genetic basis of cancer of the kidney: disease-specific approaches to therapy. Clin Cancer Res. 2004;10: 6282s-6289s.
22.
Linehan WM, Walther MM, Zbar B.The genetic basis of cancer of the kidney. J Urol.2003;170: 2163-2172.
23.
Gnarra JR, Tory K, Weng Y, et al.Mutation of the VHL tumor suppressor gene in renal carcinoma. Nat Genet.1994;7: 85-90.
24.
Herman JG, Latif F, Weng Y, et al.Silencing of the VHL tumor suppressor gene by DNA methylation in renal carcinoma. Proc Natl Acad Sci USA. 1994;91: 9700-9704.
25.
Sabo E, Boltenko A, Sova Y, Stein A, Kleinhaus S, Resnick MB.Microscopic analysis and significance of vascular architectural complexity in renal cell carcinoma. Clin Cancer Res. 2001;7: 533-537.
26.
Chow WH, Gridley G, Fraumeni JF, Järvholm B.Obesity, hypertension, and the risk of kidney cancer in men. N Engl J Med.2000;343: 1305-1311.
27.
Shapiro JA, Williams MA, Weiss NS, Stergachis A, LaCroix AZ, Barlow WE.Hypertension, antihypertensive medication use and risk of renal cell carcinoma. Am J Epidemiol.1999;149: 521-530.
28.
Vasbinder BC, Nelemans PJ, Kessels AGH, et al.Accuracy of tomographic angiography and magnetic resonance angiography for diagnosing renal artery stenosis. Ann Intern Med. 2004;141: 674-682.
29.
Parasuraman R, Attallah N, Venkat KK, et al.Rapid progression of native renal artery fibromuscular dysplasia following kidney donation. Am J Transplant. 2004;4: 1910-1914.
30.
Batelja Vuleti? L, Mladinov D, Tomić K, Vučić M, Belicza M, Krušlin B.Morphometrical analysis of renal arteries in patients with renal cell carcinoma. (Abstract). Virchows Arch.2005;447: 505-506.
